Medicare telehealth waivers and hospital-at-home programs expired on Sept. 30, risking reduced access to telehealth services for Medicare patients and operational pauses in hospital-at-home programs. Stakeholders call for permanent regulatory solutions.
Vermont Blue Advantage will terminate Medicare Advantage plans at end of 2025, prompting members to select new coverage during the Medicare Annual Enrollment Period. Key details on plan options, guaranteed issue rights, and regulatory guidance for Vermont residents.
Blue Shield of California introduces new 2026 Medicare plans emphasizing affordability, expanded benefits, and enhanced pharmacy services during Medicare's Annual Enrollment Period.
Aetna announces its 2026 Medicare Advantage plans featuring expanded supplemental benefits, enhanced Special Needs Plans, and affordable prescription drug coverage across 43 states.
Alignment Health Plan announces its 2026 Medicare Advantage portfolio with 68 plans across five states, featuring expanded special needs coverage and competitive Part B rebates.
Essence Healthcare announces 2026 Medicare Advantage plans in Central Arkansas, offering high-quality, affordable coverage with strong CMS star ratings and added member benefits.
Humana’s 2026 Medicare Advantage and Prescription Drug Plans emphasize simplicity, stability, and expanded access, with lowered premiums and enhanced benefits for Medicare beneficiaries nationwide.
The American Hospital Association urges CMS and HHS to enforce prior authorization reforms to reduce hospital staff workload and patient delays, emphasizing implementation of electronic standards and monitoring compliance.
AARP's nonpartisan advocacy efforts focus on protecting Medicare and Social Security amid funding challenges and policy changes. Learn about recent campaigns and member engagement strategies.
The Trump administration introduces WISeR, an AI-driven pilot program expanding prior authorization in Medicare to reduce wasteful services, raising industry and regulatory debates on care delays and oversight.
